Ticker
ATNMCompany Name
ACTINIUM PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -9.58% | $ 48.04M | $ 4.6M |
3/31/2025 | -31.54% | $ 46.17M | $ 14.56M |
12/31/2024 | -58.4% | $ 50.23M | $ 29.33M |
9/30/2024 | -59.3% | $ 51.47M | $ 30.52M |
6/30/2024 | -37.25% | $ 77.26M | $ 28.78M |
3/31/2024 | -14.11% | $ 204.61M | $ 28.87M |
12/31/2023 | -6.46% | $ 230.17M | $ 14.87M |
9/30/2023 | -14.79% | $ 125.55M | $ 18.57M |
6/30/2023 | -10.12% | $ 170.89M | $ 17.29M |
3/31/2023 | -10.13% | $ 236.1M | $ 23.93M |
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for ACTINIUM PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 54.74M ]) / Market Cap [ $ 153.26M ]
(=) Buyback Yield [ -35.72% ]
Minimum
Mar 31, 2021
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.71% |